Wasim K. Bleibel

Partner @Locke Lord Llp

Chicago, IL, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2022 — Present

Partner @Locke Lord Llp

View department →

Chicago, IL, US

EDUCATION

2008 — 2011

University of Illinois Chicago School of Law

JD, Intellectual Property

1997 — 2002

Michigan State University

Bachelor of Arts, Chemistry

ABOUT WASIM K. BLEIBEL

I counsel biotechnology, pharmaceutical, beverage, and digital/media tech clients on intellectual property litigation, portfolio strategy, brand protection/enforcement, social media, marketing and corporate policies, and regulatory compliance. I also serve as Chair of my firm\'s Hispanic Affinity Group.I have significant experience representing both patent owners and accused infringers in complex patent litigation matters. I have been involved in numerous contested proceedings before the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board and those arising under the Hatch-Waxman Act.I also regularly provide strategic advice to major corporations, mid-size companies, startups, and other publicly traded and privately held businesses to ensure compliance with relevant marketing and advertising regulations, including those arising under the Federal Food, Drug and Cosmetic Act, Federal Trade Commission Act and industry organizations. I also assist those companies on social media policies, influencer agreements, endorsements, brand protection and brand strategy.I also represent companies in the seed and agricultural biotechnology industries in connection with regulatory, intellectual property, liability and transactional matters. Among the types of clients I have represented: biotechnology trait providers, seed producers, seed dealers, seed distributors, and seedsmen\'s errors and omissions insurers.Prior to my legal career, I was a senior research scientist at the University of Chicago, where I worked to identify genetic determinants contributing to a patient\'s sensitivity to chemotherapeutic agents. My contributions resulted in my laboratory being the first to demonstrate that drug sensitivity to chemotherapy is a heritable genetic trait and that these responses vary across and within founder populationsFor inquires, please contact me at:(31••••••38

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Wasim K. Bleibel — Partner at Locke Lord Llp in Chicago, IL, US | Unifers